June 7, 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Genital swabs testing begins and assay development is underway. Oral PrEP modeling completed. Collaboration in Kenya continues. Resources being developed for training and M&E. Genital swabs testing begins and assay development is underway. In collaboration with… Read more »
June 7, 2017
EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy. Project VOGUE underway. Project VOGUE underway. EMOTION is currently preparing for Project VOGUE, a socio-behavioral study comparing the human-centered design (HCD) branded experience and product to unbranded product and… Read more »
February 27, 2017
GEMS informs policies and defines programmatic considerations related to use of ARV-based HIV prevention products and risk of resistance. Genital swabs testing begins and assay development is underway. Initial oral PrEP modeling completed. Collaboration in Kenya and Namibia continues. Genital swabs testing begins and assay development is underway. GEMS has collaborated with Partners PrEP and… Read more »
February 27, 2017
OPTIONS presented two posters at CROI 2017 in February focused on modeling work in Kenya: “Cost-effectiveness of pre-exposure prophylaxis across counties in Western Kenya” and “HIV transmission in generalized, concentrated, and mixed epidemics in Western Kenya.” GEMS also presented the poster, “Does the E138A Mutation in ASPIRE Seroconverters Affect Susceptibility to Dapivirine?”
February 27, 2017
EMOTION increases uptake and correct and consistent use of ARV-based HIV prevention products by women at high risk of HIV infection using an end-user centered strategy. Pilot messaging study completed. Socio-behavioral study underway. Pilot messaging study completed. Project Siyavala, the pilot messaging study, builds on findings from Project Kalahari, which focused on the “End User Journey”… Read more »
February 27, 2017
POWER develops cost-effective and scalable models for implementation of ARV-based HIV prevention products for women. POWER formative report finalized. Community survey about oral PrEP underway. POWER open label oral PrEP cohort launch scheduled. Pre-testing of oral PrEP decision support tool initiated. POWER formative report finalized. The POWER team submitted the final report of the results… Read more »
February 27, 2017
CHARISMA supports efforts to: increase women’s agency to safely use ARV-based HIV prevention, to engage male partners in HIV prevention, and to overcome harmful gender norms and reduce intimate partner violence (IPV). Clinic-based intervention launched. Community-based intervention continues. Intervention evaluations and reporting planned. Clinic-based intervention launched. CHARISMA received Wits RHI ethics approval to initiate the… Read more »
February 27, 2017
Regional representatives of OPTIONS, POWER, CHARISMA, and GEMS shared country experiences and lessons learned from their current MPii work about how to address HIV prevention for adolescent girls and young women (AGYW) in Eastern and Southern Africa during “HIV prevention and sexual and reproductive health and rights for adolescent girls and young women.” Co-convened by… Read more »